ATP-sensitive K ϩ (K ATP ) channel openers are vasodilators that activate both plasma membrane and mitochondrial K ATP channels. Here, we investigated the molecular mechanisms by which diazoxide and pinacidil induce vasodilation by studying diameter regulation of wild-type [SUR2(ϩ/ϩ)] and sulfonylurea receptor (SUR) 2-deficient [SUR2(Ϫ/Ϫ)] mouse myogenic mesenteric arteries. Ryanodine (10 M), a ryanodine-sensitive Ca 2ϩ release (RyR) channel blocker; iberiotoxin (100 nM), a large-conductance Ca 2ϩ -activated K ϩ (K Ca ) channel blocker; 4-aminopyridine (4-AP; 1 mM), a voltage-gated K ϩ (K V ) channel blocker; manganese(III) tetrakis(1-methyl-4-pyridyl)porphyrin (MnTMPyP; 100 M), an antioxidant; and a combination of ryanodine and 4-AP reduced diazoxide (100 M)-induced dilation in pressurized (60 mm Hg) SUR2(ϩ/ϩ) arteries by 45 to 77%. In contrast, these inhibitors did not alter pinacidil (5 M)-induced dilation in SUR2(ϩ/ϩ) arteries. Reverse transcription-polymerase chain reaction indicated that SUR2B was the only SUR isoform expressed in SUR2(ϩ/ϩ) mesenteric artery smooth muscle cells, whereas SURs were absent in SUR2(Ϫ/Ϫ) cells. In SUR2(Ϫ/Ϫ) arteries, pinacidil-induced vasodilation was ϳ10% of that in SUR2(ϩ/ϩ) arteries, whereas diazoxide-induced vasodilation was similar in SUR2(ϩ/ϩ) and SUR2(Ϫ/Ϫ) arteries. Atpenin (1 M), a selective electron transport chain (ETC) complex II inhibitor, dilated arteries similarly to diazoxide, and this effect was attenuated by MnTMPyP and ryanodine ϩ 4-AP. Atpenin also attenuated diazoxide-, but not pinacidil-induced vasodilation. In summary, data indicate that pinacidil-induced vasodilation requires SUR2B, whereas diazoxide-induced vasodilation does not require SURs. Rather, diazoxide-induced vasodilation involves ETC II inhibition; a smooth muscle cell-reactive oxygen species elevation; and RyR, K Ca , and K V channel activation. These data indicate that K ATP channel openers regulate arterial diameter via SUR-dependent and -independent pathways.Plasma membrane ATP-sensitive K ϩ (pmK ATP ) channels couple changes in cellular metabolic activity to membrane electrical excitability (Ashcroft and Ashcroft, 1990). K ATP channels are composed of pore-forming K ir 6.x and regulatory sulfonylurea receptor (SUR) subunits . The assembly of four K ir 6.x and four SUR subunits results in tissue-specific K ATP channel complexes with different functional, electrophysiological, and pharmacological properties .SURs are members of the ATP-binding cassette transporter protein superfamily that are predicted to form 17 transmembrane-spanning helices and two intracellular nucleotide binding domains (Tusná dy et al., 1997). Two distinct SUR isoforms (SUR1 and SUR2) have been identified that are ϳ70% identical . Alternative splicing of the SUR2 gene at the 3Ј end results in two additional isoforms, SUR2A and SUR2B, that have different pharmacological profiles (Isomoto et al., 1996). SURs are the molecular target of pharmacologically diverse and clinically important agonists and antagonists. ...